CD19 and neoplasm: Considering the metastasis progression observed in the group treated twice with CD19 CAR-T (CD3z-CD28) cells (Figure 2b), we investigated the activation of the endogenous immune response triggered by CAR-T cells and the participation of chicken embryo immune cells in the tumor challenge.